These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8640868)

  • 1. Inhibition of apoptosis and augmentation of lymphoproliferation in bcl-2 transgenic Fas/Fas ligand-defective mice.
    Tamura A; Katsumata M; Greene MI; Yui K
    Cell Immunol; 1996 Mar; 168(2):220-8. PubMed ID: 8640868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-dependent reduction of Bcl-2 expression in peripheral T cells of lpr and gld mutant mice.
    Tamura A; Yui K
    J Immunol; 1995 Jul; 155(1):499-507. PubMed ID: 7602121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis signaling pathways in normal T cells: differential activity of Bcl-2 and IL-1beta-converting enzyme family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity.
    Moreno MB; Memon SA; Zacharchuk CM
    J Immunol; 1996 Nov; 157(9):3845-9. PubMed ID: 8892614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
    Zipp F; Martin R; Lichtenfels R; Roth W; Dichgans J; Krammer PH; Weller M
    J Immunol; 1997 Sep; 159(5):2108-15. PubMed ID: 9278296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in sensitivity of peripheral lymphocytes of autoimmune gld mice to FasL-mediated apoptosis reveal a mechanism for the preferential deletion of CD4-CD8-B220+ T cells.
    Xiao S; Zhang X; Mann KK; Jodo S; Li L; Jarjour WN; Marshak-Rothstein A; Sherr DH; Ju ST
    Int Immunol; 2004 May; 16(5):759-66. PubMed ID: 15096479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CrmA expression in T lymphocytes of transgenic mice inhibits CD95 (Fas/APO-1)-transduced apoptosis, but does not cause lymphadenopathy or autoimmune disease.
    Smith KG; Strasser A; Vaux DL
    EMBO J; 1996 Oct; 15(19):5167-76. PubMed ID: 8895561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the Bcl-2 and Fas molecules in experimental apoptosis of spleen B lymphocytes.
    Alvarado C; Alarcón-Riquelme ME; Alcocer-Varela J; Fernández C
    Rev Invest Clin; 1997; 49(3):171-8. PubMed ID: 9294959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired peripheral deletion of activated T cells in mice lacking the common cytokine receptor gamma-chain: defective Fas ligand expression in gamma-chain-deficient mice.
    Nakajima H; Leonard WJ
    J Immunol; 1997 Nov; 159(10):4737-44. PubMed ID: 9366397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas system-mediated apoptosis suppresses lymphopoiesis.
    Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
    J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional roles of Fas and Bcl-2-regulated apoptosis of T lymphocytes.
    Van Parijs L; Biuckians A; Abbas AK
    J Immunol; 1998 Mar; 160(5):2065-71. PubMed ID: 9498742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract.
    Suzuki A; Matsuzawa A; Iguchi T
    Oncogene; 1996 Jul; 13(1):31-7. PubMed ID: 8700551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
    Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
    J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
    Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
    J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subclass of dendritic cells regulates the response of naive CD8 T cells by limiting their IL-2 production.
    Kronin V; Winkel K; Süss G; Kelso A; Heath W; Kirberg J; von Boehmer H; Shortman K
    J Immunol; 1996 Nov; 157(9):3819-27. PubMed ID: 8892611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
    Ashany D; Savir A; Bhardwaj N; Elkon KB
    J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of the aryl hydrocarbon receptor in T-lineage cells induces thymus involution independently of the Fas/Fas ligand signaling pathway.
    Nagai H; Kubo M; Abe R; Yamamoto M; Nohara K
    Int Immunopharmacol; 2006 Feb; 6(2):279-86. PubMed ID: 16399633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand.
    Suda T; Tanaka M; Miwa K; Nagata S
    J Immunol; 1996 Nov; 157(9):3918-24. PubMed ID: 8892623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
    Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
    J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax.
    Aggarwal S; Gupta S
    J Immunol; 1998 Feb; 160(4):1627-37. PubMed ID: 9469419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.